Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells

Experimental Cell Research

Volumn 313, Issue 6, 2007, Pages 1172-1180

  Andersson, Elin K I ^a,b   Irvin, Dwain K ^a,c   Ahlsiö, Jessica ^a   Parmar, Malin ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cell replacement; Dopamine; In vitro differentiation; Midbrain; Neurosphere; Ngn2; Nurr1; Retrovirus; TH

Indexed keywords

NGN2 PROTEIN; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; GENE; GENE OVEREXPRESSION; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; STEM CELL; VIRAL GENE DELIVERY SYSTEM;

EID: 33947206784     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.12.014     Document Type: Article

References (37)

1. Bayer S.A., Wills K.V., Triarhou L.C., and Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp. Brain Res. 105 (1995) 191-199
2. Prakash N., and Wurst W. Genetic networks controlling the development of midbrain dopaminergic neurons. J. Physiol. (2006)
3. Prakash N., and Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci. 63 (2006) 187-206
4. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T., and Ericson J. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124 (2006) 393-405
5. Maxwell S.L., Ho H.Y., Kuehner E., Zhao S., and Li M. Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev. Biol. 282 (2005) 467-479
6. Wagner J., Akerud P., Castro D.S., Holm P.C., Canals J.M., Snyder E.Y., Perlmann T., and Arenas E. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat. Biotechnol. 17 (1999) 653-659
7. Chung S., Sonntag K.C., Andersson T., Bjorklund L.M., Park J.J., Kim D.W., Kang U.J., Isacson O., and Kim K.S. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 16 (2002) 1829-1838
8. Kim D.W., Chung S., Hwang M., Ferree A., Tsai H.C., Park J.J., Chung S., Nam T.S., Kang U.J., Isacson O., and Kim K.S. Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells 24 (2006) 557-567
9. Kim J.Y., Koh H.C., Lee J.Y., Chang M.Y., Kim Y.C., Chung H.Y., Son H., Lee Y.S., Studer L., McKay R., and Lee S.H. Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J. Neurochem. 85 (2003) 1443-1454
10. Sonntag K.C., Simantov R., Kim K.S., and Isacson O. Temporally induced Nurr1 can induce a non-neuronal dopaminergic cell type in embryonic stem cell differentiation. Eur. J. Neurosci. 19 (2004) 1141-1152
11. Bertrand N., Castro D.S., and Guillemot F. Proneural genes and the specification of neural cell types. Nat. Rev., Neurosci. 3 (2002) 517-530
12. Fode C., Ma Q., Casarosa S., Ang S.L., Anderson D.J., and Guillemot F. A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons. Genes Dev. 14 (2000) 67-80
13. Kele J., Simplicio N., Ferri A.L., Mira H., Guillemot F., Arenas E., and Ang S.L. Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133 (2006) 495-505
14. Thompson L.H., Andersson E., Jensen J.B., Barraud P., Guillemot F., Parmar M., and Bjorklund A. Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon. Exp. Neurol. 198 (2006) 183-198
15. Andersson E., Jensen J.B., Parmar M., Guillemot F., and Bjorklund A. Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development 133 (2006) 507-516
16. Falk A., Holmstrom N., Carlen M., Cassidy R., Lundberg C., and Frisen J. Gene delivery to adult neural stem cells. Exp. Cell Res. 279 (2002) 34-39
17. Chung S., Shin B.S., Hwang M., Lardaro T., Kang U.J., Isacson O., and Kim K.S. Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24 (2006) 1583-1593
18. Roybon L., Brundin P., and Li J.Y. Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes. Exp. Neurol. 196 (2005) 373-380
19. Ko J.Y., Lee J.Y., Park C.H., and Lee S.H. Effect of cell-density on in-vitro dopaminergic differentiation of mesencephalic precursor cells. NeuroReport 16 (2005) 499-503
20. Yan J., Studer L., and McKay R.D. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J. Neurochem. 76 (2001) 307-311
21. Ory D.S., Neugeboren B.A., and Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11400-11406
22. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., and Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276 (1997) 248-250
23. Zetterstrom R.H., Williams R., Perlmann T., and Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 41 (1996) 111-120
24. Smits S.M., Ponnio T., Conneely O.M., Burbach J.P., and Smidt M.P. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18 (2003) 1731-1738
25. Castillo S.O., Baffi J.S., Palkovits M., Goldstein D.S., Kopin I.J., Witta J., Magnuson M.A., and Nikodem V.M. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell. Neurosci. 11 (1998) 36-46
26. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., and Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4013-4018
27. Kim T.E., Lee H.S., Lee Y.B., Hong S.H., Lee Y.S., Ichinose H., Kim S.U., and Lee M.A. Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell. Biochem. Biophys. Res. Commun. 305 (2003) 1040-1048
28. Schutz B., Schafer M.K., Eiden L.E., and Weihe E. Ontogeny of vesicular amine transporter expression in the rat: new perspectives on aminergic neuronal and neuroendocrine differentiation. Adv. Pharmacol. 42 (1998) 903-908
29. Jensen C.H., Meyer M., Schroder H.D., Kliem A., Zimmer J., and Teisner B. Neurons in the monoaminergic nuclei of the rat and human central nervous system express FA1/dlk. NeuroReport 12 (2001) 3959-3963
30. Simon H.H., Saueressig H., Wurst W., Goulding M.D., and O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21 (2001) 3126-3134
31. Alberi L., Sgado P., and Simon H.H. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131 (2004) 3229-3236
32. Smidt M.P., van Schaick H.S., Lanctot C., Tremblay J.J., Cox J.J., van der Kleij A.A., Wolterink G., Drouin J., and Burbach J.P. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13305-13310
33. Smidt M.P., Smits S.M., and Burbach J.P. Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur. J. Pharmacol. 480 (2003) 75-88
34. Kosaka K., Aika Y., Toida K., Heizmann C.W., Hunziker W., Jacobowitz D.M., Nagatsu I., Streit P., Visser T.J., and Kosaka T. Chemically defined neuron groups and their subpopulations in the glomerular layer of the rat main olfactory bulb. Neurosci. Res. 23 (1995) 73-88
35. Kim H.J., Sugimori M., Nakafuku M., and Svendsen C.N. Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Exp. Neurol. (2006)
36. Park C.H., Kang J.S., Kim J.S., Chung S., Koh J.Y., Yoon E.H., Jo A.Y., Chang M.Y., Koh H.C., Hwang S., Suh-Kim H., Lee Y.S., Kim K.S., and Lee S.H. Differential actions of the proneural genes encoding Mash1 and neurogenins in Nurr1-induced dopamine neuron differentiation. J. Cell Sci. 119 (2006) 2310-2320
37. Hudson J.L., Bickford P., Johansson M., Hoffer B.J., and Stromberg I. Target and neurotransmitter specificity of fetal central nervous system transplants: importance for functional reinnervation. J. Neurosci. 14 (1994) 283-290